Clinical Trial Update: Study to Describe the Allergic Reactions to Factor IX in Patients With Hemophilia B

View source ↗

Summary

A completed clinical trial update describing allergic reactions to Factor IX in patients with Hemophilia B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Factor IX (coagulation factor IX)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Hemophilia B, Allergic Reactions | Status: COMPLETED